CCRP Therapeutics is a biopharmaceutical spin-off of Charité's Center for
Cardiovascular Research (CCR), supported by the German Federal Ministry
of Education and Research (BMBF) under its GO-Bio initiative.
The company's focus is the discovery of Breakthrough drugs in indications
with common pathophysiological mechanisms and high unmet medical need. In
collaboration with major pharmaceutical companies innovative therapeutic
approces will be further advanced and commercialized.